209 related articles for article (PubMed ID: 22534729)
1. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.
Olson ES; Whitney MA; Friedman B; Aguilera TA; Crisp JL; Baik FM; Jiang T; Baird SM; Tsimikas S; Tsien RY; Nguyen QT
Integr Biol (Camb); 2012 Jun; 4(6):595-605. PubMed ID: 22534729
[TBL] [Abstract][Full Text] [Related]
2. Identification of High-Risk Plaques by MRI and Fluorescence Imaging in a Rabbit Model of Atherothrombosis.
Hua N; Baik F; Pham T; Phinikaridou A; Giordano N; Friedman B; Whitney M; Nguyen QT; Tsien RY; Hamilton JA
PLoS One; 2015; 10(10):e0139833. PubMed ID: 26448434
[TBL] [Abstract][Full Text] [Related]
3. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
4. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
[TBL] [Abstract][Full Text] [Related]
5. Thrombin-Activatable Microbubbles as Potential Ultrasound Contrast Agents for the Detection of Acute Thrombosis.
Lux J; Vezeridis AM; Hoyt K; Adams SR; Armstrong AM; Sirsi SR; Mattrey RF
ACS Appl Mater Interfaces; 2017 Nov; 9(43):37587-37596. PubMed ID: 28994575
[TBL] [Abstract][Full Text] [Related]
6. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
Berry CN; Girardot C; Lecoffre C; Lunven C
Thromb Haemost; 1994 Sep; 72(3):381-6. PubMed ID: 7855788
[TBL] [Abstract][Full Text] [Related]
7. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes.
van Duijnhoven SM; Robillard MS; Hermann S; Kuhlmann MT; Schäfers M; Nicolay K; Grüll H
Mol Pharm; 2014 May; 11(5):1415-23. PubMed ID: 24641497
[TBL] [Abstract][Full Text] [Related]
8. Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful?
Curvers J; van de Kerkhof D; Stroobants AK; van den Dool EJ; Scharnhorst V
Am J Clin Pathol; 2012 Oct; 138(4):551-8. PubMed ID: 23010710
[TBL] [Abstract][Full Text] [Related]
9. Thrombin activity associated with neuronal damage during acute focal ischemia.
Chen B; Friedman B; Whitney MA; Winkle JA; Lei IF; Olson ES; Cheng Q; Pereira B; Zhao L; Tsien RY; Lyden PD
J Neurosci; 2012 May; 32(22):7622-31. PubMed ID: 22649241
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin.
Callas DD; Hoppensteadt D; Fareed J
Semin Thromb Hemost; 1995; 21(2):177-83. PubMed ID: 7660140
[TBL] [Abstract][Full Text] [Related]
11. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
[TBL] [Abstract][Full Text] [Related]
12. Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing.
Gosselin RC; King JH; Janatpur KA; Dager WH; Larkin EC; Owings JT
Arch Pathol Lab Med; 2004 Oct; 128(10):1142-5. PubMed ID: 15387708
[TBL] [Abstract][Full Text] [Related]
13. Direct thrombin inhibitors.
Kaplan KL
Expert Opin Pharmacother; 2003 May; 4(5):653-66. PubMed ID: 12739991
[TBL] [Abstract][Full Text] [Related]
14. Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.
Felsen CN; Savariar EN; Whitney M; Tsien RY
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L764-74. PubMed ID: 24508733
[TBL] [Abstract][Full Text] [Related]
15. Development of Radiolabeled Membrane Type-1 Matrix Metalloproteinase Activatable Cell Penetrating Peptide Imaging Probes.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Molecules; 2015 Jul; 20(7):12076-92. PubMed ID: 26147581
[TBL] [Abstract][Full Text] [Related]
16. Direct thrombin inhibitors in cardiac disease.
Weitz JI; Bates ER
Cardiovasc Toxicol; 2003; 3(1):13-25. PubMed ID: 12668887
[TBL] [Abstract][Full Text] [Related]
17. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1.
Riewald M; Kravchenko VV; Petrovan RJ; O'Brien PJ; Brass LF; Ulevitch RJ; Ruf W
Blood; 2001 May; 97(10):3109-16. PubMed ID: 11342437
[TBL] [Abstract][Full Text] [Related]
18. Thrombin inhibitor argatroban modulates bone marrow stromal cells behaviors and promotes osteogenesis through canonical Wnt signaling.
Song J; Jiang N; Gan X; Zhi W; Zhu Z
Life Sci; 2021 Mar; 269():119073. PubMed ID: 33460666
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent.
Sharma R; Waller AP; Agrawal S; Wolfgang KJ; Luu H; Shahzad K; Isermann B; Smoyer WE; Nieman MT; Kerlin BA
J Am Soc Nephrol; 2017 Sep; 28(9):2618-2630. PubMed ID: 28424276
[TBL] [Abstract][Full Text] [Related]
20. Role of thrombin in the pathogenesis of atherosclerosis.
Jaberi N; Soleimani A; Pashirzad M; Abdeahad H; Mohammadi F; Khoshakhlagh M; Khazaei M; Ferns GA; Avan A; Hassanian SM
J Cell Biochem; 2019 Apr; 120(4):4757-4765. PubMed ID: 30269382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
